nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Laboratory test abnormal—Entecavir—hepatitis B	0.0379	0.0379	CcSEcCtD
Gadoversetamide—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.0247	0.0247	CcSEcCtD
Gadoversetamide—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.0189	0.0189	CcSEcCtD
Gadoversetamide—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0162	0.0162	CcSEcCtD
Gadoversetamide—Rhinorrhoea—Telbivudine—hepatitis B	0.016	0.016	CcSEcCtD
Gadoversetamide—Chest discomfort—Telbivudine—hepatitis B	0.0147	0.0147	CcSEcCtD
Gadoversetamide—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.0145	0.0145	CcSEcCtD
Gadoversetamide—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.0139	0.0139	CcSEcCtD
Gadoversetamide—Neck pain—Telbivudine—hepatitis B	0.0132	0.0132	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Entecavir—hepatitis B	0.0108	0.0108	CcSEcCtD
Gadoversetamide—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.0106	0.0106	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0105	0.0105	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00989	0.00989	CcSEcCtD
Gadoversetamide—Amblyopia—Lamivudine—hepatitis B	0.00949	0.00949	CcSEcCtD
Gadoversetamide—Rhinorrhoea—Lamivudine—hepatitis B	0.00904	0.00904	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Entecavir—hepatitis B	0.00896	0.00896	CcSEcCtD
Gadoversetamide—Dysphonia—Lamivudine—hepatitis B	0.00891	0.00891	CcSEcCtD
Gadoversetamide—Haematuria—Entecavir—hepatitis B	0.00844	0.00844	CcSEcCtD
Gadoversetamide—Nasopharyngitis—Telbivudine—hepatitis B	0.00844	0.00844	CcSEcCtD
Gadoversetamide—Vasodilation procedure—Lamivudine—hepatitis B	0.00834	0.00834	CcSEcCtD
Gadoversetamide—Vasodilation—Lamivudine—hepatitis B	0.00834	0.00834	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00832	0.00832	CcSEcCtD
Gadoversetamide—Muscular weakness—Telbivudine—hepatitis B	0.00832	0.00832	CcSEcCtD
Gadoversetamide—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00824	0.00824	CcSEcCtD
Gadoversetamide—Influenza—Telbivudine—hepatitis B	0.00816	0.00816	CcSEcCtD
Gadoversetamide—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0081	0.0081	CcSEcCtD
Gadoversetamide—Oedema peripheral—Entecavir—hepatitis B	0.00783	0.00783	CcSEcCtD
Gadoversetamide—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.0077	0.0077	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00766	0.00766	CcSEcCtD
Gadoversetamide—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0076	0.0076	CcSEcCtD
Gadoversetamide—Eructation—Lamivudine—hepatitis B	0.0072	0.0072	CcSEcCtD
Gadoversetamide—Immune system disorder—Entecavir—hepatitis B	0.00718	0.00718	CcSEcCtD
Gadoversetamide—Mental disorder—Entecavir—hepatitis B	0.00696	0.00696	CcSEcCtD
Gadoversetamide—Malnutrition—Entecavir—hepatitis B	0.00692	0.00692	CcSEcCtD
Gadoversetamide—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00675	0.00675	CcSEcCtD
Gadoversetamide—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00665	0.00665	CcSEcCtD
Gadoversetamide—Back pain—Adefovir Dipivoxil—hepatitis B	0.00653	0.00653	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Telbivudine—hepatitis B	0.0065	0.0065	CcSEcCtD
Gadoversetamide—Pharyngitis—Telbivudine—hepatitis B	0.00648	0.00648	CcSEcCtD
Gadoversetamide—Sleep disorder—Lamivudine—hepatitis B	0.00614	0.00614	CcSEcCtD
Gadoversetamide—Cough—Adefovir Dipivoxil—hepatitis B	0.00589	0.00589	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Telbivudine—hepatitis B	0.00588	0.00588	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00585	0.00585	CcSEcCtD
Gadoversetamide—Injury—Lamivudine—hepatitis B	0.00579	0.00579	CcSEcCtD
Gadoversetamide—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00575	0.00575	CcSEcCtD
Gadoversetamide—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00575	0.00575	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00571	0.00571	CcSEcCtD
Gadoversetamide—Malnutrition—Telbivudine—hepatitis B	0.00568	0.00568	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Entecavir—hepatitis B	0.00565	0.00565	CcSEcCtD
Gadoversetamide—Thirst—Lamivudine—hepatitis B	0.00559	0.00559	CcSEcCtD
Gadoversetamide—Dysgeusia—Telbivudine—hepatitis B	0.00557	0.00557	CcSEcCtD
Gadoversetamide—Nervous system disorder—Entecavir—hepatitis B	0.00554	0.00554	CcSEcCtD
Gadoversetamide—Back pain—Telbivudine—hepatitis B	0.0055	0.0055	CcSEcCtD
Gadoversetamide—Skin disorder—Entecavir—hepatitis B	0.00548	0.00548	CcSEcCtD
Gadoversetamide—Muscle spasms—Telbivudine—hepatitis B	0.00546	0.00546	CcSEcCtD
Gadoversetamide—Hypoglycaemia—Lamivudine—hepatitis B	0.00545	0.00545	CcSEcCtD
Gadoversetamide—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0054	0.0054	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00539	0.00539	CcSEcCtD
Gadoversetamide—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00535	0.00535	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Telbivudine—hepatitis B	0.00527	0.00527	CcSEcCtD
Gadoversetamide—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00525	0.00525	CcSEcCtD
Gadoversetamide—Malaise—Telbivudine—hepatitis B	0.00513	0.00513	CcSEcCtD
Gadoversetamide—Insomnia—Entecavir—hepatitis B	0.00511	0.00511	CcSEcCtD
Gadoversetamide—Somnolence—Entecavir—hepatitis B	0.00502	0.00502	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00502	0.00502	CcSEcCtD
Gadoversetamide—Dyspepsia—Entecavir—hepatitis B	0.00497	0.00497	CcSEcCtD
Gadoversetamide—Cough—Telbivudine—hepatitis B	0.00496	0.00496	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Entecavir—hepatitis B	0.00487	0.00487	CcSEcCtD
Gadoversetamide—Fatigue—Entecavir—hepatitis B	0.00487	0.00487	CcSEcCtD
Gadoversetamide—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00485	0.00485	CcSEcCtD
Gadoversetamide—Arthralgia—Telbivudine—hepatitis B	0.00484	0.00484	CcSEcCtD
Gadoversetamide—Myalgia—Telbivudine—hepatitis B	0.00484	0.00484	CcSEcCtD
Gadoversetamide—Chest pain—Telbivudine—hepatitis B	0.00484	0.00484	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00481	0.00481	CcSEcCtD
Gadoversetamide—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00479	0.00479	CcSEcCtD
Gadoversetamide—Discomfort—Telbivudine—hepatitis B	0.00478	0.00478	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00476	0.00476	CcSEcCtD
Gadoversetamide—Nasopharyngitis—Lamivudine—hepatitis B	0.00476	0.00476	CcSEcCtD
Gadoversetamide—Muscular weakness—Lamivudine—hepatitis B	0.00469	0.00469	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00469	0.00469	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Entecavir—hepatitis B	0.00462	0.00462	CcSEcCtD
Gadoversetamide—Dysphagia—Lamivudine—hepatitis B	0.0046	0.0046	CcSEcCtD
Gadoversetamide—Influenza—Lamivudine—hepatitis B	0.0046	0.0046	CcSEcCtD
Gadoversetamide—Nervous system disorder—Telbivudine—hepatitis B	0.00455	0.00455	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Telbivudine—hepatitis B	0.00454	0.00454	CcSEcCtD
Gadoversetamide—Skin disorder—Telbivudine—hepatitis B	0.00451	0.00451	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.0045	0.0045	CcSEcCtD
Gadoversetamide—Sweating increased—Lamivudine—hepatitis B	0.00448	0.00448	CcSEcCtD
Gadoversetamide—Abdominal pain—Entecavir—hepatitis B	0.00446	0.00446	CcSEcCtD
Gadoversetamide—Body temperature increased—Entecavir—hepatitis B	0.00446	0.00446	CcSEcCtD
Gadoversetamide—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00435	0.00435	CcSEcCtD
Gadoversetamide—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00435	0.00435	CcSEcCtD
Gadoversetamide—Dysuria—Lamivudine—hepatitis B	0.0043	0.0043	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00423	0.00423	CcSEcCtD
Gadoversetamide—Insomnia—Telbivudine—hepatitis B	0.0042	0.0042	CcSEcCtD
Gadoversetamide—Paraesthesia—Telbivudine—hepatitis B	0.00416	0.00416	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Lamivudine—hepatitis B	0.00415	0.00415	CcSEcCtD
Gadoversetamide—Dyspepsia—Telbivudine—hepatitis B	0.00408	0.00408	CcSEcCtD
Gadoversetamide—Asthenia—Entecavir—hepatitis B	0.00405	0.00405	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Telbivudine—hepatitis B	0.004	0.004	CcSEcCtD
Gadoversetamide—Fatigue—Telbivudine—hepatitis B	0.004	0.004	CcSEcCtD
Gadoversetamide—Pain—Telbivudine—hepatitis B	0.00397	0.00397	CcSEcCtD
Gadoversetamide—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00395	0.00395	CcSEcCtD
Gadoversetamide—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0039	0.0039	CcSEcCtD
Gadoversetamide—Epistaxis—Lamivudine—hepatitis B	0.00387	0.00387	CcSEcCtD
Gadoversetamide—Diarrhoea—Entecavir—hepatitis B	0.00386	0.00386	CcSEcCtD
Gadoversetamide—Sinusitis—Lamivudine—hepatitis B	0.00385	0.00385	CcSEcCtD
Gadoversetamide—Feeling abnormal—Telbivudine—hepatitis B	0.00382	0.00382	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Telbivudine—hepatitis B	0.00379	0.00379	CcSEcCtD
Gadoversetamide—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00377	0.00377	CcSEcCtD
Gadoversetamide—Dizziness—Entecavir—hepatitis B	0.00373	0.00373	CcSEcCtD
Gadoversetamide—Rhinitis—Lamivudine—hepatitis B	0.00369	0.00369	CcSEcCtD
Gadoversetamide—Abdominal pain—Telbivudine—hepatitis B	0.00367	0.00367	CcSEcCtD
Gadoversetamide—Body temperature increased—Telbivudine—hepatitis B	0.00367	0.00367	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Lamivudine—hepatitis B	0.00366	0.00366	CcSEcCtD
Gadoversetamide—Pharyngitis—Lamivudine—hepatitis B	0.00365	0.00365	CcSEcCtD
Gadoversetamide—Vomiting—Entecavir—hepatitis B	0.00359	0.00359	CcSEcCtD
Gadoversetamide—Rash—Entecavir—hepatitis B	0.00356	0.00356	CcSEcCtD
Gadoversetamide—Dermatitis—Entecavir—hepatitis B	0.00356	0.00356	CcSEcCtD
Gadoversetamide—Headache—Entecavir—hepatitis B	0.00354	0.00354	CcSEcCtD
Gadoversetamide—Vomiting—Adefovir Dipivoxil—hepatitis B	0.0035	0.0035	CcSEcCtD
Gadoversetamide—Erythema multiforme—Lamivudine—hepatitis B	0.00348	0.00348	CcSEcCtD
Gadoversetamide—Rash—Adefovir Dipivoxil—hepatitis B	0.00347	0.00347	CcSEcCtD
Gadoversetamide—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00347	0.00347	CcSEcCtD
Gadoversetamide—Headache—Adefovir Dipivoxil—hepatitis B	0.00345	0.00345	CcSEcCtD
Gadoversetamide—Nausea—Entecavir—hepatitis B	0.00335	0.00335	CcSEcCtD
Gadoversetamide—Asthenia—Telbivudine—hepatitis B	0.00333	0.00333	CcSEcCtD
Gadoversetamide—Immune system disorder—Lamivudine—hepatitis B	0.00332	0.00332	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Lamivudine—hepatitis B	0.00332	0.00332	CcSEcCtD
Gadoversetamide—Chills—Lamivudine—hepatitis B	0.0033	0.0033	CcSEcCtD
Gadoversetamide—Pruritus—Telbivudine—hepatitis B	0.00328	0.00328	CcSEcCtD
Gadoversetamide—Nausea—Adefovir Dipivoxil—hepatitis B	0.00327	0.00327	CcSEcCtD
Gadoversetamide—Malnutrition—Lamivudine—hepatitis B	0.0032	0.0032	CcSEcCtD
Gadoversetamide—Erythema—Lamivudine—hepatitis B	0.0032	0.0032	CcSEcCtD
Gadoversetamide—Diarrhoea—Telbivudine—hepatitis B	0.00317	0.00317	CcSEcCtD
Gadoversetamide—Flatulence—Lamivudine—hepatitis B	0.00316	0.00316	CcSEcCtD
Gadoversetamide—Tension—Lamivudine—hepatitis B	0.00314	0.00314	CcSEcCtD
Gadoversetamide—Dysgeusia—Lamivudine—hepatitis B	0.00314	0.00314	CcSEcCtD
Gadoversetamide—Nervousness—Lamivudine—hepatitis B	0.00311	0.00311	CcSEcCtD
Gadoversetamide—Back pain—Lamivudine—hepatitis B	0.0031	0.0031	CcSEcCtD
Gadoversetamide—Muscle spasms—Lamivudine—hepatitis B	0.00308	0.00308	CcSEcCtD
Gadoversetamide—Dizziness—Telbivudine—hepatitis B	0.00307	0.00307	CcSEcCtD
Gadoversetamide—Tremor—Lamivudine—hepatitis B	0.003	0.003	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Lamivudine—hepatitis B	0.00297	0.00297	CcSEcCtD
Gadoversetamide—Vomiting—Telbivudine—hepatitis B	0.00295	0.00295	CcSEcCtD
Gadoversetamide—Rash—Telbivudine—hepatitis B	0.00292	0.00292	CcSEcCtD
Gadoversetamide—Dermatitis—Telbivudine—hepatitis B	0.00292	0.00292	CcSEcCtD
Gadoversetamide—Headache—Telbivudine—hepatitis B	0.00291	0.00291	CcSEcCtD
Gadoversetamide—Malaise—Lamivudine—hepatitis B	0.00289	0.00289	CcSEcCtD
Gadoversetamide—Vertigo—Lamivudine—hepatitis B	0.00288	0.00288	CcSEcCtD
Gadoversetamide—Syncope—Lamivudine—hepatitis B	0.00287	0.00287	CcSEcCtD
Gadoversetamide—Loss of consciousness—Lamivudine—hepatitis B	0.00282	0.00282	CcSEcCtD
Gadoversetamide—Cough—Lamivudine—hepatitis B	0.00279	0.00279	CcSEcCtD
Gadoversetamide—Convulsion—Lamivudine—hepatitis B	0.00278	0.00278	CcSEcCtD
Gadoversetamide—Nausea—Telbivudine—hepatitis B	0.00276	0.00276	CcSEcCtD
Gadoversetamide—Chest pain—Lamivudine—hepatitis B	0.00273	0.00273	CcSEcCtD
Gadoversetamide—Myalgia—Lamivudine—hepatitis B	0.00273	0.00273	CcSEcCtD
Gadoversetamide—Arthralgia—Lamivudine—hepatitis B	0.00273	0.00273	CcSEcCtD
Gadoversetamide—Anxiety—Lamivudine—hepatitis B	0.00272	0.00272	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00271	0.00271	CcSEcCtD
Gadoversetamide—Discomfort—Lamivudine—hepatitis B	0.00269	0.00269	CcSEcCtD
Gadoversetamide—Dry mouth—Lamivudine—hepatitis B	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Confusional state—Lamivudine—hepatitis B	0.00264	0.00264	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Lamivudine—hepatitis B	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Oedema—Lamivudine—hepatitis B	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Shock—Lamivudine—hepatitis B	0.00257	0.00257	CcSEcCtD
Gadoversetamide—Nervous system disorder—Lamivudine—hepatitis B	0.00256	0.00256	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Lamivudine—hepatitis B	0.00256	0.00256	CcSEcCtD
Gadoversetamide—Skin disorder—Lamivudine—hepatitis B	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Lamivudine—hepatitis B	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Anorexia—Lamivudine—hepatitis B	0.00249	0.00249	CcSEcCtD
Gadoversetamide—Hypotension—Lamivudine—hepatitis B	0.00244	0.00244	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00238	0.00238	CcSEcCtD
Gadoversetamide—Insomnia—Lamivudine—hepatitis B	0.00236	0.00236	CcSEcCtD
Gadoversetamide—Paraesthesia—Lamivudine—hepatitis B	0.00235	0.00235	CcSEcCtD
Gadoversetamide—Dyspnoea—Lamivudine—hepatitis B	0.00233	0.00233	CcSEcCtD
Gadoversetamide—Somnolence—Lamivudine—hepatitis B	0.00232	0.00232	CcSEcCtD
Gadoversetamide—Dyspepsia—Lamivudine—hepatitis B	0.0023	0.0023	CcSEcCtD
Gadoversetamide—Decreased appetite—Lamivudine—hepatitis B	0.00227	0.00227	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00226	0.00226	CcSEcCtD
Gadoversetamide—Fatigue—Lamivudine—hepatitis B	0.00225	0.00225	CcSEcCtD
Gadoversetamide—Constipation—Lamivudine—hepatitis B	0.00224	0.00224	CcSEcCtD
Gadoversetamide—Pain—Lamivudine—hepatitis B	0.00224	0.00224	CcSEcCtD
Gadoversetamide—Feeling abnormal—Lamivudine—hepatitis B	0.00215	0.00215	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Lamivudine—hepatitis B	0.00214	0.00214	CcSEcCtD
Gadoversetamide—Urticaria—Lamivudine—hepatitis B	0.00208	0.00208	CcSEcCtD
Gadoversetamide—Abdominal pain—Lamivudine—hepatitis B	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Body temperature increased—Lamivudine—hepatitis B	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Hypersensitivity—Lamivudine—hepatitis B	0.00193	0.00193	CcSEcCtD
Gadoversetamide—Asthenia—Lamivudine—hepatitis B	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Pruritus—Lamivudine—hepatitis B	0.00185	0.00185	CcSEcCtD
Gadoversetamide—Diarrhoea—Lamivudine—hepatitis B	0.00179	0.00179	CcSEcCtD
Gadoversetamide—Dizziness—Lamivudine—hepatitis B	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Vomiting—Lamivudine—hepatitis B	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Rash—Lamivudine—hepatitis B	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Dermatitis—Lamivudine—hepatitis B	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Headache—Lamivudine—hepatitis B	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Nausea—Lamivudine—hepatitis B	0.00155	0.00155	CcSEcCtD
